1. Home
  2. NKTX vs PROV Comparison

NKTX vs PROV Comparison

Compare NKTX & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • PROV
  • Stock Information
  • Founded
  • NKTX 2015
  • PROV 1956
  • Country
  • NKTX United States
  • PROV United States
  • Employees
  • NKTX N/A
  • PROV N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • PROV Savings Institutions
  • Sector
  • NKTX Health Care
  • PROV Finance
  • Exchange
  • NKTX Nasdaq
  • PROV Nasdaq
  • Market Cap
  • NKTX 123.5M
  • PROV 102.0M
  • IPO Year
  • NKTX 2020
  • PROV 1996
  • Fundamental
  • Price
  • NKTX $1.97
  • PROV $15.59
  • Analyst Decision
  • NKTX Strong Buy
  • PROV Hold
  • Analyst Count
  • NKTX 5
  • PROV 1
  • Target Price
  • NKTX $13.50
  • PROV $16.50
  • AVG Volume (30 Days)
  • NKTX 539.6K
  • PROV 6.3K
  • Earning Date
  • NKTX 11-06-2025
  • PROV 10-27-2025
  • Dividend Yield
  • NKTX N/A
  • PROV 3.59%
  • EPS Growth
  • NKTX N/A
  • PROV N/A
  • EPS
  • NKTX N/A
  • PROV 0.93
  • Revenue
  • NKTX N/A
  • PROV $39,666,000.00
  • Revenue This Year
  • NKTX N/A
  • PROV $7.74
  • Revenue Next Year
  • NKTX N/A
  • PROV $4.06
  • P/E Ratio
  • NKTX N/A
  • PROV $16.76
  • Revenue Growth
  • NKTX N/A
  • PROV 1.90
  • 52 Week Low
  • NKTX $1.31
  • PROV $12.98
  • 52 Week High
  • NKTX $6.49
  • PROV $16.70
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 41.11
  • PROV 57.02
  • Support Level
  • NKTX $2.00
  • PROV $15.35
  • Resistance Level
  • NKTX $2.08
  • PROV $15.79
  • Average True Range (ATR)
  • NKTX 0.11
  • PROV 0.20
  • MACD
  • NKTX -0.03
  • PROV 0.02
  • Stochastic Oscillator
  • NKTX 2.35
  • PROV 68.75

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.

Share on Social Networks: